Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market
Holding TARS?
Track your performance easily

Tarsus Pharmaceuticals (TARS) Income Statement

179 Followers

Tarsus Pharmaceuticals Income Statement

Last quarter (Q2 2024), Tarsus Pharmaceuticals's total revenue was $40.81M, an increase of 1532.52% from the same quarter last year. In Q2, Tarsus Pharmaceuticals's net income was $-31.18M. See Tarsus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 55.76M$ 17.45M$ 25.82M$ 57.03M$ 0.00$ 0.00
Cost of Revenue
$ 4.60M$ 1.59M$ -955.00K$ -2.08M$ 0.00-
Gross Profit
$ 51.16M$ 15.85M$ 24.36M$ 54.95M$ 0.00-
Operating Expense
$ 204.26M$ 159.01M$ -88.53M$ -69.18M$ 27.00M$ 4.30M
Operating Income
$ -151.51M$ -143.16M$ -63.21M$ -12.16M$ -27.00M$ -4.30M
Net Non Operating Interest Income Expense
$ 9.53M$ 6.99M$ 1.30M$ 36.00K$ 188.00K$ -40.00K
Other Income Expense
$ 1.68M$ 274.00K$ 182.00K$ 664.00K-$ -331.00K
Pretax Income
$ -143.66M$ -135.89M$ -62.09M$ -13.77M$ -26.81M$ -4.67M
Tax Provision
$ -4.40M$ -4.40M$ -4.00K$ 55.00K$ 1.00K$ 1.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -143.66M$ -135.89M$ -62.09M$ -12.84M$ -26.81M$ -4.67M
Basic EPS
$ -4.59$ -4.62$ -2.52$ -0.67$ -4.32$ -1.09
Diluted EPS
$ -4.59$ -4.62$ -2.52$ -0.67$ -4.32$ -1.09
Basic Average Shares
$ 128.61M$ 29.38M$ 24.62M$ 20.55M$ 6.21M$ 4.29M
Diluted Average Shares
$ 128.61M$ 29.38M$ 24.62M$ 20.55M$ 6.21M$ 4.29M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 208.86M$ 160.60M$ -89.48M$ -71.26M$ 27.00M$ 4.30M
Net Income From Continuing And Discontinued Operation
$ -145.76M$ -135.89M$ -62.09M$ -12.84M$ -26.81M$ -4.67M
Normalized Income
$ -132.93M$ -140.30M--$ -26.81M$ -4.43M
Interest Expense
------
EBIT
$ -139.54M$ -132.67M$ -61.79M$ -13.81M$ -27.00M$ -4.30M
EBITDA
$ -101.86M$ -131.79M$ -62.00M$ -13.20M$ -26.90M$ -4.26M
Currency in USD

Tarsus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis